Dotmatics Licenses Their Integrated Suite of Solutions forPre-Clinical Research Informatics to Basilea
BISHOPS STORTFORD, UNITED KINGDOM, May 08, 2012 (Menafn - MARKETWIRE via COMTEX) --Dotmatics Ltd, a leading provider of informatics services to thepharmaceutical and biotechnology industries, today announced thatBasilea Pharmaceutica International Ltd have licensed and globallydeployed Dotmatics' entire suite of scientific informatics solutionsfor pre-clinical research data management.
The Dotmatics platform provides for registering, analyzing andmanaging scientific data, an electronic laboratory notebook forchemistry and biology experiments, the ability to query and reportresearch data, and to visualize with chemical intelligence.
Basilea CSO, Laurenz Kellenberger, PhD, states, "With the integratedDotmatics platform tailored to Basilea's specific needs, we arefurther enhancing the way we globally consolidate and learn frombiological and chemical research data. We look forward to continueworking with Dotmatics to efficiently address our future informaticsrequirements in chemistry and biology."
"We are really excited to have this opportunity to provide a suite oftools for global deployment in Basilea's research group and to beable to collaborate with them," said Stephen Gallagher, PHD and CEOof Dotmatics. "We are committed to delivering high quality solutionsand services to ensure that the informatics requirements of Basilea'sR & D are fulfilled" he added.
About Dotmatics
Dotmatics has rapidly emerged as a preferred informatics supplier tomany of the top global pharmaceutical, biotechnology, and academicorganisations. Dotmatics is a scientific software company deployingweb-based knowledge solutions that dramatically improve the wayscientific data is queried, managed and shared within companies.Dotmatics has significant expertise in chem- and bioinformaticstechniques including chemical databases, SAR analysis, datamanagement and data visualization. A privately owned company,Dotmatics was founded in 2005 and has its head office based south ofCambridge, UK.
Solution Highlights:
Browser - Web-based tool for querying, browsing and visualizingbiological databases such as IDBS' ActivityBase(TM) and any chemicaldatabase.
Vortex - World-class visualization and analytics platform forscientific and non-scientific data.
D40 - Chemistry enabling MS Office.
Bioregister - Web-based tool for registering Biological entities.
Gateway - Securely enables research teams to share informationinternally and with external partners.
Pinpoint - Powerful Oracle chemical cartridge for querying andintegrating chemical databases(i). Pinpoint represents world-classindexing and search performance at a cost-effective price.
Register - Flexible and scalable chemical registration system.
Nucleus - Map and import biological and non-biological data filesinto an Oracle database.
Studies - The new standard in screening data management.
Studies Notebook - Web-based ELN for all disciplines.
(i)Pinpoint is developed in collaboration with Astex Therapeutics Ltd
About Basilea
Basilea Pharmaceutica Ltd. is a listed (six:BSLN) Swissbiopharmaceutical company focused on research, development andcommercialization of drugs that address the medical challenge ofrising resistance and non-response to current treatment options inthe hospital and specialty care setting in the areas of bacterial andfungal infections, oncology and skin diseases.
Contacts:
Enquiries:
Dotmatics Limited
44(0)1279 654 123
44(0)1279 653 088 (FAX)
info@dotmatics.com
www.dotmatics.com
SOURCE: Dotmatics Limited
mailto:info@dotmatics.com
http://www.dotmatics.com
Copyright 2012 Marketwire, Inc., All rights reserved.
